Biodesix Inc. (BDSX) reported Q4 EPS of ($0.35), $0.07 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $9.61 million versus the consensus estimate of $10.77 million.
Biodesix Inc. (BDSX) reported Q4 EPS of ($0.35), $0.07 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $9.61 million versus the consensus estimate of $10.77 million.